EIF4A2 or ANKRD46 expression and survival in BC patients. (a) Representative TMAs sections stained for ANKRD46 and EIF4A2 from different BC. Examples for staining score 0 (negative), 3, 5 and 7 of marker expression are shown. All images were taken at × 200. (b) Kaplan-Meier survival curve and log-rank test for 99 BC patients showing five-year overall survival. ANKRD46 expression had no significant relationship to patient survival (P = 0.146). High EIF4A2 expression was associated with significantly improved OS (P = 0.044) in women with BC. TMAs, tissue microarrays; OS, overall survival.